Capital Genomix

Capital Genomix is a privately held biotechnology company located in Gaithersburg, Maryland. The Company was founded in August, 2000 to develop, commercialize and exploit two proprietary technologies, GeneSystem320 and ImmunoMouse.The team at Capital Genomix is dedicated to its Mission to build shareholder value by utilizing genomic and proteomic technologies to develop novel gene and antibody - based drugs and diagnostics. In order to accomplish this goal, Capital Genomix has built a team of exceptional scientists and business professionals to convert the vision of the Company. More about Capital Genomix is available through the links and contact information provided below:

Contact Information including a company directory.

Career Information and job opportunities are available at our Careers page.